An international trial on 945 patients found treatment with ipilimumab and nivolumab stopped the cancer advancing for nearly a year in 58% of cases.
UK doctors presented the data at the American Society of Clinical Oncology.
Cancer Research UK said the drugs deliver a "powerful punch" against one of the most aggressive forms of cancer.
Help employers find you! Check out all the jobs and post your resume.
UK doctors presented the data at the American Society of Clinical Oncology.
Cancer Research UK said the drugs deliver a "powerful punch" against one of the most aggressive forms of cancer.
Help employers find you! Check out all the jobs and post your resume.
